BioCentury
ARTICLE | Clinical News

Bevirimat: Phase IIb data

November 3, 2008 8:00 AM UTC

An Australian Phase IIb (Study 204) trial in 32 patients with HIV showed that bevirimat met the primary endpoint of demonstrating bevirimat plasma levels to be well above 20 µg/mL, which is the previo...